Back
Lyell Immunopharma Stock Price Chart
Sponsored
LYEL
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
38
LYEL
Lyell Immunopharma
Last Price:
1.22
Seasonality Move:
-24.64%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing buying pressure, which is a positive indicator for future bullish movement.
Lyell Immunopharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.02 | Buy |
20-day SMA: | 1.1 | Buy |
50-day SMA: | 1.25 | Buy |
200-day SMA: | 1.88 | Sell |
8-day EMA: | 1.08 | Buy |
20-day EMA: | 1.11 | Buy |
50-day EMA: | 1.25 | Buy |
200-day EMA: | 1.75 | Sell |
Lyell Immunopharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 57.47 | Buy |
Chaikin Money Flow: | 1432987 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.01 - 1.25) | Buy |
Bollinger Bands (100): | (1.13 - 1.77) | Sell |
Lyell Immunopharma Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Lyell Immunopharma Stock
Is Lyell Immunopharma Stock a Buy?
- Lyell Immunopharma share price is 1.28 while LYEL 8-day simple moving average is 1.02, which is a Buy signal.
- The stock price of LYEL is 1.28 while Lyell Immunopharma 20-day SMA is 1.10, which makes it a Buy.
- Lyell Immunopharma 50-day simple moving average is 1.25 while LYEL share price is 1.28, making it a Buy technically.
- LYEL stock price is 1.28 and Lyell Immunopharma 200-day simple moving average is 1.88, creating a Sell signal.
LYEL Technical Analysis vs Fundamental Analysis
Sell
38
Lyell Immunopharma (LYEL)
is a Sell
Is Lyell Immunopharma a Buy or a Sell?
-
Lyell Immunopharma stock is rated a Sell
The current Lyell Immunopharma [LYEL] share price is $1.28. The Score for LYEL is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Lyell Immunopharma Stock Info
Market Cap:
327.68M
Price in USD:
1.28
Share Volume:
1.86M
Lyell Immunopharma 52-Week Range
52-Week High:
3.26
52-Week Low:
0.85
Sell
38
Lyell Immunopharma (LYEL)
is a Sell
Lyell Immunopharma Share Price Forecast
-
What is the Lyell Immunopharma stock price today?
The Lyell Immunopharma stock price is 1.28 USD today. -
Will LYEL stock go up or go down?
Lyell Immunopharma> share price is forecast to RISE/FALL based on technical indicators -
Is Lyell Immunopharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Lyell Immunopharma is overvalued.
Is Lyell Immunopharma Stock a Buy?
- Lyell Immunopharma share price is 1.28 while LYEL 8-day exponential moving average is 1.08, which is a Buy signal.
- The stock price of LYEL is 1.28 while Lyell Immunopharma 20-day EMA is 1.11, which makes it a Buy.
- Lyell Immunopharma 50-day exponential moving average is 1.25 while LYEL share price is 1.28, making it a Buy technically.
- LYEL stock price is 1.28 and Lyell Immunopharma 200-day simple moving average is 1.75, creating a Sell signal.
Fundamental Analysis of Lyell Immunopharma
Is Lyell Immunopharma a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.04 per share.
Technical Analysis of Lyell Immunopharma
Should I short Lyell Immunopharma stock?
- LYEL Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Lyell Immunopharma is a Sell
- Lyell Immunopharma Relative Strength Index (RSI) is 57.47, which suggest Lyell Immunopharma is overbought
- The Bollinger Bands (25) for Lyell Immunopharma is (1.01 - 1.25), which suggest Lyell Immunopharma is a Sell
- The Bollinger Bands (100) for Lyell Immunopharma is (1.13 - 1.77), which suggest Lyell Immunopharma is a Sell
* Lyell Immunopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.